Homing of unfractionated BM-expressing soluble VEGFR2 as an angiogenesis inhibitor suppresses tumor growth [19], although expression of such a soluble receptor could theoretically affect the VEGF-dependent tumoral migration of EPCs [15]. This evidence concerns the gene VEGFA and neoplasm.